Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients
Objectives Recent Zika virus (ZIKV) outbreaks challenged existing laboratory diagnostic standards, especially for serology‐based methods. Because of the genetic and structural similarity of ZIKV with other flaviviruses, this results in cross‐reactive antibodies, which confounds serological interpret...
Main Authors: | Amrun, SN, Yee, W-X, Abu Bakar, F, Lee, B, Kam, Y-W, Lum, F-M, Tan, JJ, Lim, VW, Watthanaworawit, W, Ling, C, Nosten, F, Renia, L, Leo, Y-S, Ng, LF |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Publishing Group
2019
|
Similar Items
-
Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
by: Siti Naqiah Amrun, et al.
Published: (2019) -
Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection
by: Fernandez, E, et al.
Published: (2017) -
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections
by: Kam, Yiu-Wing, et al.
Published: (2018) -
The epitope arrangement on flavivirus particles contributes to Mab C10’s extraordinary neutralization breadth across Zika and dengue viruses
by: Sharma, A, et al.
Published: (2021) -
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein
by: Kam, Y.W., et al.
Published: (2012)